|
A word from
our President
As we move through the first months of 2024, I look forward with anticipation and optimism to the developments in Canada's life sciences sector.
This optimism is validated by the first white paper from the adMare Institute, Canada's Evolving Life Sciences Industry: Exploring Ecosystems, Clusters, and the Need for Anchor Companies, focusing on an element vital to our collective success – the pivotal role of anchor companies within our ecosystem.
The data are clear that anchor companies are essential for a sustainable life science cluster, and that being an anchor company is a deliberate process that starts early. By accepting the challenge to build anchors, we understand that it means behaving like anchor companies. What that really means is that we must consider the market at every step to build a robust and integrated sector. There are a lot of companies already behaving this way and setting the example. I invite you to review the findings of our inaugural white paper, reflect on our shared objectives within this vibrant ecosystem, and engage in the dialogue on how we can be sure Canadian life sciences lead the world.
As we drive forward ahead in 2024, let's also drive the growth of Canada's life sciences sector, creating not only a more sustainable industry but also delivering innovative healthcare solutions to the world.
Respectfully,
Gordon C. McCauley
President and CEO, adMare BioInnovations
Building Companies
Domain Therapeutics, an adMare porfolio company, announced two positive developments
Domain Therapeutics strengthens leadership team to spearhead global development and North American expansion as the leading GPCR immuno-oncology company.
Domain Therapeutics awarded Hospital-University Research in Health (RHU) SPRINT consortium grant to progress its proprietary CCR8 antibody candidate to the clinic.
Thryv Therapeutics, an adMare porfolio company, presented benefits of therapeutic SGK1 inhibition with THRV-1268 in a murine model of atrial fibrillation
"This pre-clinical study with THRV-1268 demonstrated statistically significant reductions in the frequency of induced arrhythmias and atrial fibrillation-related events in mice fed with a high fat diet. These data combined with the positive improvement in inflammatory and fibrotic signals proposes this SGK1 inhibitor as a novel therapeutic for the treatment of atrial fibrillation and potentially heart failure," said Pirouz Shamszad, MD, Senior Vice President, Clinical Development at Thryv.
Zymeworks, an adMare porfolio company, announced updated Phase 2a data showcasing potential of zanidatamab in HER2+/HR+ metastatic breast cancer
Zymeworks announced, along with their partners Jazz Pharmaceuticals, updated data from the Phase 2a trial of investigational zanidatamab, a HER2-targeted bispecific antibody, in combination with palbociclib, a CDK4/6 inhibitor, and fulvestrant, a selective estrogen receptor antagonist, in patients with HER2-positive/HR-positive metastatic breast cancer as part of a late-breaking oral presentation at the 2023 San Antonio Breast Cancer Symposium.
On February 6th, the MaRS adMare Tx Accelerator hosted an event for Ontario's most promising early-stage life sciences therapeutics ventures
Held at the Mars Discover Centre in Toronto, this event convened life sciences innovators ready to bridge the gap between academia and commercial launch. Learn how the adMare National Tx Accelerator can help you scale up your venture.
Building Ecosystems
Access Canada's life sciences ecosystem
adMare BioInnovations recently launched a revamped version of the adMare Community and we encourage all life science professionnals to join us to Discover, Connect and Access Canada's life sciences ecosystem.
Whether you're looking to broaden and build professional relationships, explore the latest industry news, events and job opportunities, or gain access to mentorship and professional development, discover what the adMare Community can do for you.
Discover the Community at a glance
Discover the power of precision with adMare BioInnovations' analytical services
Choosing adMare's analytical services offers access to cutting-edge technology, an expert team dedicated to innovation, and accelerated results. Our efficient processes are ensuring high-quality and precise outcomes, and they are designed to keep your biotech projects moving forward.
In the Media
Anchor company 'mindset' critical to growing Canada's life sciences sector
Watch this BIV podcast episode with Hayley Woodin and Gordon C. McCauley
A question of leadership - Looking for a Quebec leader in pharma
Read an interview with Mounia Azzi, Vice President, Corporate Development, at adMare, in La Presse.
Canada's life sciences industry needs anchor firms to create world-class clusters: report
Read this Research Money article to learn more about the conclusions of adMare Institute white paper and their significance.
Anchor companies' vital role in global life sciences innovation
An interview with Gordon C. McCauley published in Techouver summarizing the adMare Institute white paper.
Innovating the Canadian biotech sector with Joseph Mancini, Vice President Research at adMare BioInnovations
Learn more about how adMare scientists are developing tomorrow's therapies in this interview published in Pharma Features.
Upcoming Events
Life sciences: anchor companies as an international springboard for Quebec?
Join us to hear our President and CEO, Gordon C. McCauley, presenting the key findings of the adMare Institute white paper, and hear our guests' views on the topic.
Date: February 21, 11:30 a.m. ET
Location: Le Westin Hotel, Montreal, QC
Are anchor companies the missing link in the success of Quebec's life sciences industry?
Québec VITAE and Québec International, in collaboration with adMare BioInnovations, invite you to a breakfast conference on anchor companies and their role in the future of the healthcare industry. Are they the key to making Quebec a world-class life sciences innovation cluster?
Date: February 22, 7:30 a.m. ET
Location: Chateau Laurier Hotel, Quebec City, QC
adMare Discovery Session: Future-Proofing Biomanufacturing: Navigating Challenges and Innovating for Tomorrow
Join us on March 5th for a special adMare Discovery Session featuring Killian O'Driscoll, Chief Commercial Officer of the National Institute for Bioprocessing Research and Training (NIBRT).
A Look Back at our Recent Events
adMare Industry Builder Series featuring Dr David Altshuler: Humanizing Drug Discovery
Dr. David Altshuler discussed the importance of humanizing drug discovery with critical insights.
If you missed his presentation, the recording will be available this week on the Resources page of the adMare Community.
Join the adMare Community
today and you'll never miss a life sciences event again!
Building Talent
CASTL partners with Moderna Canada to ready workforce at Laval manufacturing site
The Canadian Alliance for Skills and Training in Life Sciences (CASTL) announced they have signed a memorandum of understanding (MOU) with Moderna Canada to support biomanufacturing training for employees at Moderna's new vaccine manufacturing facility in Laval, Quebec.
adMare BioInnovations welcomed 22 influential Life Sciences leaders to Cohort VI of the adMare Academy Executive Institute
The Executive Institute is an eight-month, custom-designed executive development program. During the program, professionals in the life sciences sector develop their leadership abilities in collaboration with industry peers, benefiting from their collective experiences within the Canadian life sciences landscape.
CASTL opened biomanufacturing training facility in quebec
The Canadian Alliance for Skills and Training in Life Sciences (CASTL) unveiled its new biomanufacturing training facility in Montreal, Quebec yesterday afternoon. Located at the Angus Technopole in east Montreal, the new facility responds to the demand for highly skilled personnel in Quebec's growing biomanufacturing sector by offering a wide range of technical bioprocessing training.
adMare BioInnovations
Vancouver
2405 Wesbrook Mall
Vancouver, British Columbia, Canada
V6T 1Z3
Toronto
Toronto, Ontario, Canada
M5G 1L7
Montreal
Montréal, Québec, Canada
H4S 1Z9
 |